Technology

For people with type 2 diabetes who use insulin, a major shift may be on the horizon. Two new once-weekly basal insulins, efsitora alpha and insulin icodec, have shown results comparable to today's best daily insulins in clinical trials, with no increase in hypoglycemia, and 2026 may be the year one receives approval.

Taking Control Of Your Diabetes® Fewer injections could mean simpler routines and better consistency. Ask your care team if this is something to watch for in your own management plan.

🔗 Source: TCOYD – Diabetes Predictions 2026

Researchers are pairing AI with wearable devices to forecast glucose changes hours before they happen, potentially helping you make smarter food and activity choices in real time. The science is promising, but experts say the next big challenge is making these tools trustworthy and accessible for everyone, not just the tech-savvy. Worth watching closely!

Source: https://www.nature.com/articles/s41746-025-02036-9

Imagine a world where your smartwatch not only tracks your steps but predicts your blood sugar spikes hours before they happen, guiding your meals, activity, and insulin in real time. 

Recent research shows AI paired with wearables is moving us toward that reality for type 2 diabetes, yet most tools still operate with limited transparency and demographic reach. 

The real challenge isn’t the tech, it’s trust, transparency, and equity: can these systems truly serve everyone, not just those who are already digitally connected? 

The future of diabetes care may hinge on making AI not just smart, but explainable, inclusive, and actionable.

Source: https://www.nature.com/articles/s41746-025-02036-9

Explore how digital tools, apps, and AI are transforming type 2 diabetes management for better self-care and outcomes.

Key Highlights:

✅ Technology transforms diabetes self-management

✅ Apps and devices support real-time monitoring

✅ AI predicts glucose trends and patterns